Technology advances in diabetes pregnancy: right technology, right person, right time
A McLean, L Maple-Brown, HR Murphy - Diabetologia, 2024 - Springer
This review outlines some of the extraordinary recent advances in diabetes technology,
which are transforming the management of type 1 diabetes before, during and after …
which are transforming the management of type 1 diabetes before, during and after …
Effect of automated insulin delivery systems on person-reported outcomes in people with diabetes: a systematic review and meta-analysis
T Roos, N Hermanns, C Groß, B Kulzer, T Haak… - …, 2024 - thelancet.com
Background Conclusive evidence on the benefits of automated insulin delivery (AID)
systems on person-reported outcomes (PROs) is missing. Methods In this systematic review …
systems on person-reported outcomes (PROs) is missing. Methods In this systematic review …
Real‐world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta‐analysis
Q Yang, B Zeng, J Hao, Q Yang… - Diabetes, Obesity and …, 2024 - Wiley Online Library
Aim To evaluate the real‐world effectiveness of automated insulin delivery (AID) systems in
patients with type 1 diabetes (T1D). Materials and Methods PubMed, Embase, the Cochrane …
patients with type 1 diabetes (T1D). Materials and Methods PubMed, Embase, the Cochrane …
Person‐reported outcomes in diabetes care: What are they and why are they so important?
N Hermanns, B Kulzer… - Diabetes, Obesity and …, 2024 - Wiley Online Library
In this review, we aim to show how person‐reported outcomes (PROs) and person‐reported
experiences (PREs) can significantly contribute to the way diabetes care is delivered, the …
experiences (PREs) can significantly contribute to the way diabetes care is delivered, the …
Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by …
C Quirós, MT Herrera Arranz, J Amigó… - Diabetes Technology …, 2024 - liebertpub.com
Aims: To compare glycemic control and maternal–fetal outcomes of women with type 1
diabetes (T1D) using hybrid closed loop (HCL) versus multiple daily insulin injections (MDI) …
diabetes (T1D) using hybrid closed loop (HCL) versus multiple daily insulin injections (MDI) …
Response to Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control …
PI Beato-Víbora, A Chico, J Moreno-Fernandez… - Diabetes …, 2024 - Am Diabetes Assoc
We would like to express our gratitude to Lebbar et al.(1) for their interest in our work (2) and
for their valuable comments. We value this opportunity to provide a comprehensive …
for their valuable comments. We value this opportunity to provide a comprehensive …
Characteristics of people with type 1 diabetes influence the educational process for starting insulin pump therapy: an observational study
V Izquierdo, M Pazos-Couselo… - Health Education …, 2024 - academic.oup.com
Limited data exist on educational programs for people using insulin pump (IP) therapy or
those considering its initiation, and the influence of individual characteristics on their …
those considering its initiation, and the influence of individual characteristics on their …
Patient‐reported outcomes in studies of diabetes technology: What matters
AL Liarakos, TSJ Crabtree… - Diabetes, Obesity and …, 2024 - Wiley Online Library
In recent years, diabetes technologies have revolutionized the care of people with type 1
diabetes (T1D). Emerging evidence suggests that people with type 2 diabetes (T2D) can …
diabetes (T1D). Emerging evidence suggests that people with type 2 diabetes (T2D) can …
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 Diabetes
A Bhargava, RM Bergenstal, ML Warren… - Diabetes Technology …, 2025 - liebertpub.com
Background: Early feasibility studies have demonstrated safe and effective automated
insulin delivery use in individuals with suboptimally controlled type 2 diabetes (T2D). The …
insulin delivery use in individuals with suboptimally controlled type 2 diabetes (T2D). The …
Precision medicine in type 1 diabetes: comparing metabolic outcomes of Control‐IQ and MiniMed 780G according to patient characteristics
I Gargouri, H Charfi, W Belabed… - Diabetes, Obesity …, 2024 - Wiley Online Library
Aims This study aimed to compare 12‐month metabolic outcomes in patients with type 1
diabetes (T1D) treated with either MiniMed 780G (Guardian 4) or Control‐IQ (Dexcom G6) …
diabetes (T1D) treated with either MiniMed 780G (Guardian 4) or Control‐IQ (Dexcom G6) …